COSCIENS Biopharma Inc. (TSX:CSCI)
Canada
· Delayed Price · Currency is CAD 4.340
+0.180 (4.33%)
Apr 23, 2025, 4:00 PM EDT
COSCIENS Biopharma Revenue
In the year 2024, COSCIENS Biopharma had annual revenue of $9.59M USD with 34.22% growth. COSCIENS Biopharma had revenue of $3.32M in the quarter ending December 31, 2024, with 20.10% growth.
Revenue
$9.59M
Revenue Growth
+34.22%
P/S Ratio
1.01
Revenue / Employee
$239.68K
Employees
40
Market Cap
14.00M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.59M | 2.44M | 34.22% |
| Dec 31, 2023 | 7.14M | -7.43M | -50.98% |
| Dec 31, 2022 | 14.57M | 9.31M | 177.03% |
| Dec 31, 2021 | 5.26M | 1.61M | 44.03% |
| Dec 31, 2020 | 3.65M | 3.12M | 586.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| WELL Health Technologies | 919.69M |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |